Harmony Biosciences Holdings, Inc. (HRMY)
36.13
+0.10
(+0.28%)
USD |
NASDAQ |
Oct 23, 16:00
36.07
-0.06
(-0.17%)
Pre-Market: 20:00
Harmony Biosciences Holdings Price to Book Value : 2.102 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.102 |
| October 22, 2026 | 2.096 |
| October 21, 2026 | 2.228 |
| October 20, 2026 | 2.251 |
| October 19, 2026 | 2.184 |
| October 16, 2026 | 2.207 |
| October 15, 2026 | 2.226 |
| October 14, 2026 | 2.182 |
| October 13, 2026 | 2.154 |
| October 12, 2026 | 2.224 |
| October 09, 2026 | 2.343 |
| October 08, 2026 | 2.303 |
| October 07, 2026 | 2.288 |
| October 06, 2026 | 2.289 |
| October 05, 2026 | 2.322 |
| October 02, 2026 | 2.306 |
| October 01, 2026 | 2.302 |
| September 30, 2026 | 2.284 |
| September 29, 2026 | 2.285 |
| September 28, 2026 | 2.327 |
| September 25, 2026 | 2.400 |
| September 24, 2026 | 2.394 |
| September 23, 2026 | 2.354 |
| September 22, 2026 | 2.416 |
| September 21, 2026 | 2.449 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.444 |
| September 17, 2026 | 2.486 |
| September 16, 2026 | 2.455 |
| September 15, 2026 | 2.453 |
| September 14, 2026 | 2.416 |
| September 11, 2026 | 2.415 |
| September 10, 2026 | 2.391 |
| September 09, 2026 | 2.421 |
| September 08, 2026 | 2.447 |
| September 04, 2026 | 2.458 |
| September 03, 2026 | 2.435 |
| September 02, 2026 | 2.493 |
| September 01, 2026 | 2.399 |
| August 31, 2026 | 2.290 |
| August 28, 2026 | 2.281 |
| August 27, 2026 | 2.319 |
| August 26, 2026 | 2.307 |
| August 25, 2026 | 2.266 |
| August 24, 2026 | 2.239 |
| August 21, 2026 | 2.219 |
| August 20, 2026 | 2.214 |
| August 19, 2026 | 2.322 |
| August 18, 2026 | 2.258 |
| August 17, 2026 | 2.218 |
| August 14, 2026 | 2.217 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 19.48 |
| Pfizer Inc. | 2.009 |
| Bristol Myers Squibb Co. | 5.628 |
| Repligen Corp. | 4.727 |
| Johnson & Johnson | 7.789 |
Price to Book Value Related Metrics
| PE Ratio | 11.71 |
| PS Ratio | 2.211 |
| Price to Free Cash Flow | 6.322 |
| Price | 36.13 |
| Earnings Yield | 8.54% |
| Market Cap | 2.100B |
| Operating PE Ratio | 9.201 |
| Normalized PE Ratio | 11.71 |